De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors.

Tomas HornakJiri MayerPetra CicatkovaLukas SemeradAnezka KvetkovaHana KlamovaEdgar FaberPetra BelohlavkovaMichal KarasLukas StejskalEduard CmuntOlga CernaDana SrbovaHana ZizkovaLucia VrablovaIvana SkoumalovaJaroslava VoglovaTereza JurkovaMarika ChrapavaTomas JurcekIvana JeziskovaMarie JarosovaKaterina Machova PolakovaTomas PapajikPavel ZakPavel JindraDaniela Zackova

Published in: American journal of hematology (2024)

Overall survival of patients classified according to the European LeukemiaNet 2020 classification. Chronic phase (CP), accelerated phase (AP), blast crisis (BC), low risk (LR), intermediate risk (IR), high risk (HR).

Keyphrases

chronic myeloid leukemia
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
public health
machine learning
deep learning
prognostic factors
patient reported outcomes